This multicenter , double-blind , randomized controlled trial ( NCT@ ) compared @-month feeding with a pectin-based TAAF ( Novalac ( ) , United Pharmaceuticals , Paris , France ) and a commercially available `` reference '' AAF ( RAAF ; Neocate ( ) , Nutricia , Germany ) in infants aged < @ months with CMPA and persistent allergy symptoms with eHF feeding .